6-溴-2-氨基萘 | 7499-66-3

• 物质功能分类: 化学试剂 - 有机试剂 - 多环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 6-溴-2-氨基萘
• 英文名称: 6-Bromonaphthalen-2-amine
• 英文别名: 6-bromo-2-naphthylamine；6-bromo-2-aminonaphthalene；2-amino-6-bromonaphthalene
• CAS: 7499-66-3
• 化学式: C₁₀H₈BrN
• mdl: MFCD01026466
• 分子量: 222.084
• InChiKey: UBLKHAWYJFEPDX-UHFFFAOYSA-N

物化性质

• 熔点：
  128 °C
• 沸点：
  155-160 °C(Press: 1 Torr)
• 密度：
  1.563±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921450090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-6-bromonaphthalene
Synonyms: 6-Bromonaphthalen-2-amine

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-6-bromonaphthalene
CAS number: 7499-66-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8BrN
Molecular weight: 222.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

6-溴-2-氨基萘是制备达塞布韦的关键中间体，还可用作液晶活性组分。这种组分能使含有该成分的液晶具有高度分散性并易于结晶，同时大幅度降低极限电压，具备极高的响应能力。

生产工艺

6-溴-2-氨基萘以很常规的2-氨基萘作为起始物料，通过二碳酸二叔丁酯保护氨基、溴素进行溴化处理，然后使用锡粉还原脱除一个溴原子。最后脱除氨基保护后成盐并纯化，从而得到目标产物。所有原料均易得且价格低廉，极大降低了生产成本。此外，该工艺操作连贯简便，无需高温高压反应，十分适合工业化生产。


反应信息

• 作为反应物：
  描述：

  6-溴-2-氨基萘 在 吡啶 、 potassium phosphate 、 tris-(dibenzylideneacetone)dipalladium(0) 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 potassium acetate 、 1,3,5,7-四甲基-6-苯基-2,4,8-三氧杂-6-磷酰金刚烷 作用下， 以 四氢呋喃 、 2-甲基四氢呋喃 、 水 为溶剂， 反应 7.0h， 生成 达沙布韦
  参考文献：
  名称：

  金属催化偶联反应在合成 HCV 聚合酶抑制剂 Dasabuvir 中的发现和发展。

  摘要：

  Dasabuvir ( 1 ) 是一种 HCV 聚合酶抑制剂，已被开发为三组分直接作用抗病毒联合疗法的一部分。在合成路线的开发过程中，开发了两种新的偶联反应。首先，发现了使用吡啶酰胺16作为配体的尿嘧啶与芳基碘化物的铜催化偶联。后来，在富电子钯配合物（包括新型膦配体 VincePhos ( 50 )）的推动下，开发了钯催化的芳基非磺酸盐33 的磺酰胺化反应。这使得达沙布韦的收敛、高效合成成为可能，显着降低了该过程的诱变杂质负担。

  DOI：

  10.1021/acs.joc.8b02690
• 作为产物：
  描述：

  6-溴-2-萘酚 在 ammonium hydroxide 、 ammonium sulfite monohydrate 作用下， 以 水 为溶剂， 反应 6.0h， 生成 6-溴-2-氨基萘
  参考文献：
  名称：

  烯烃间螯合控制的立体特异性交叉偶联反应用于轴向手性共轭二烯的阻转选择性合成

  摘要：

  在该协议中，报道了一种通过烯基 C-H 烯化有效的钯催化不对称合成轴向手性共轭二烯。相应的含有共轭二烯支架的阻转异构苯乙烯以良好的收率和良好的对映选择性获得。该合成策略具有操作简单、反应条件温和、官能度耐受性宽、效率高等特点。

  DOI：

  10.1021/acs.orglett.2c00386

文献信息

• NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
  申请人：Buckman Brad

  公开号：US20110152246A1

  公开（公告）日：2011-06-23

  The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

  实施例提供了一般式I、II、III、IV或V的化合物，以及包括药物组合物在内的组合物，其中包括一种主体化合物。实施例还提供了治疗方法，包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法，这些方法通常涉及向需要的个体施用一种主体化合物或组合物的有效量。
• [EN] ANTIVIRAL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ANTIVIRAUX ET LEURS UTILISATIONS
  申请人：ABBOTT LAB

  公开号：WO2010111437A1

  公开（公告）日：2010-09-30

  This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

  这项发明涉及：(a) 抑制HCV等化合物及其盐；(b) 用于制备这种化合物和盐的中间体；(c) 包括这种化合物和盐的组合物；(d) 制备这种中间体、化合物、盐和组合物的方法；(e) 使用这种化合物、盐和组合物的方法；以及(f) 包括这种化合物、盐和组合物的试剂盒。
• Enantioselective Construction of Axially Chiral Amino Sulfide Vinyl Arenes by Chiral Sulfide‐Catalyzed Electrophilic Carbothiolation of Alkynes
  作者：Yaoyu Liang、Jieying Ji、Xiaoyan Zhang、Quanbin Jiang、Jie Luo、Xiaodan Zhao

  DOI：10.1002/anie.201915470

  日期：2020.3.16

  The enantioselective construction of axially chiral compounds by electrophilic carbothiolation of alkynes is disclosed for the first time. This enantioselective transformation is enabled by the use of a Ts-protected bifunctional sulfide catalyst and Ms-protected ortho-alkynylaryl amines (Ts=tosyl; Ms=mesyl). Both electrophilic arylthiolating and electrophilic trifluoromethylthiolating reagents are

  首次公开了通过炔的亲电碳硫基化对轴向手性化合物的对映选择性结构。通过使用Ts保护的双官能硫化物催化剂和Ms保护的邻炔基芳基胺（Ts ＝甲苯磺酰基； Ms ＝甲磺酰基），可以实现这种对映选择性转化。亲电芳基硫醇化试剂和亲电三氟甲基硫醇化试剂均适用于该反应。轴向手性乙烯基-芳基氨基硫化物的所得产物可以容易地转化为联芳基氨基硫化物，联芳基氨基亚砜，联芳基胺，乙烯基芳基胺和其他有价值的双官能化化合物。
• [EN] GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE GLYCOLATE OXYDASE POUR LE TRAITEMENT D'UNE MALADIE
  申请人：BIOMARIN PHARM INC

  公开号：WO2020257487A1

  公开（公告）日：2020-12-24

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

  本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物，以及使用这种化合物治疗或预防与甘氧酸代谢缺陷相关的疾病或紊乱的方法，例如与甘氧酸氧化酶（GO）或草酸代谢变化相关的疾病或紊乱。这些疾病或紊乱包括与产生过多草酸相关的甘氧酸代谢紊乱，例如原发性高草酸尿症。
• 유기발광 화합물 및 이를 포함하는 유기전계발광소자
  申请人：SFC CO., LTD. 에스에프씨 주식회사(120060087061) Corp. No ▼ 135511-0105889BRN ▼134-81-54429

  公开号：KR102164014B1

  公开（公告）日：2020-10-13

  본 발명은 정공수송 재료로 채용되는 유기발광 화합물에 관한 것으로서, 하기 [화학식 1-1] 내지 [화학식 1-2]로 표시되는 것을 특징으로 하며, 본 발명에 따른 유기발광 화합물을 유기전계발광소자의 정공수송층에 채용시 발광효율 및 수명 특성이 동시에 향상된 유기전계발광소자의 제조가 가능하다. [화학식 1-1] [화학식 1-2]

  本发明涉及一种用作有机发光材料的有机发光化合物，其特征在于表示为[化学式1-1]至[化学式1-2]，根据本发明，可以制造出在有机电致发光器件的正电荷传输层中采用的有机发光化合物，从而同时提高发光效率和寿命特性。 [化学式1-1] [化学式1-2]